Phunware Inc (NASDAQ:PHUN) has been named the 2019 Patient Experience Solutions Company of the Year by analyst group Frost & Sullivan.
The company was presented with the award at the Frost & Sullivan Growth, Innovation and Leadership Awards Gala on September 17, the company announced Wednesday.
Each year, Frost & Sullivan selects a company that “demonstrates excellence in terms of growth strategy and implementation in its field,” according to a statement from the organization.
READ: Phunware Inc launches app to streamline shopper experience at Scottsdale Fashion Square in Arizona
“Phunware extended [Multiscreen-as-a-Service] to a range of verticals, offering turnkey native solutions to address various industry-specific needs,” Frost & Sullivan Program Manager Siddharth Shah said. “Leveraging its experience across industries, it created an exceptional ‘one-stop-shop’ suite of offerings designed to appeal to newcomers and incumbents in the mobile space.”
Frost & Sullivan said that one reason Phunware works especially well for patients in hospitals is that its wayfinding and other services support those who have vision or hearing impairments, or who use a wheelchair.
The company’s wayfinding technology taps into GPS, wifi, beacons internal maps and mobile location technology to help users navigate to their precise destination.
“Phunware has a proven ability to handle platform scale in real-time, both indoors and outdoors, both onshore and offshore and whether on the ground or in the air,” noted Shah.
“It is quickly achieving a massive global scale by licensing its technology to the world’s largest corporations, including such marquee names as the NFL, Fox, the Olympic Games and most recently, the Women’s World Cup. With great customers like Dignity Healthcare, Kaiser, Cedar Sinai and MD Anderson, the company anticipates rapid double-digit growth in the healthcare sector and is expected to entrench itself in this industry.”
Phunware's share price increased nearly 3% Wednesday to $1.43.
—Updated to include stock movement—
Contact Andrew Kessel at andrew.kessel@proactiveinvestors.com
Follow him on Twitter @andrew_kessel